07:00 , Apr 30, 2012 |  BC Week In Review  |  Company News

Marina Biotech, Cambridge Biolabs LLC deal

Cambridge Biolabs returned rights to use Marina's transKingdom RNAi (tkRNAi) delivery technology for agriculture and veterinary uses. Cambridge Biolabs will retain exclusive rights to use the technology for undisclosed veterinary applications, for which Marina is...